Omada Health, Inc. Common Stock (OMDA) is a publicly traded Healthcare sector company. As of May 21, 2026, OMDA trades at $16.67 with a market cap of $979.12M and a P/E ratio of -181.73. OMDA moved -0.54% today. Year to date, OMDA is +10.06%; over the trailing twelve months it is flat. Its 52-week range spans $10.28 to $28.40. Analyst consensus is strong buy with an average price target of $23.30. Rallies surfaces OMDA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Omada Health’s Q1 Revenue Jumps 42% to $78M; Members Top 1M, Adds Lilly GLP-1 Channel: Omada Health’s Q1 revenue rose 42% year-over-year to $78 million, members climbed 51% to 1.02 million, and adjusted EBITDA turned positive at $1 million. The company joined Eli Lilly’s Employer Connect program to offer its GLP-1 Care Track directly to employers with transparent net cost and defined contributions.
| Metric | Value |
|---|---|
| Price | $16.67 |
| Market Cap | $979.12M |
| P/E Ratio | -181.73 |
| EPS | $-0.09 |
| Dividend Yield | 0.00% |
| 52-Week High | $28.40 |
| 52-Week Low | $10.28 |
| Volume | 107 |
| Avg Volume | 0 |
| Revenue (TTM) | $283.30M |
| Net Income | $-6.30M |
| Gross Margin | 66.27% |
10 analysts cover OMDA: 0 strong buy, 9 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $23.30.